Transcription factor SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in several tumors, such as ovarian and pancreatic cancer, following a different and independent pathway from that of TF-PAR2-VEGF [14, 35]. The gene discussed is F2RL1; the disease is pancreatic neoplasm.